Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: Vaccine. 2011 Jul 27;29(40):6920–6927. doi: 10.1016/j.vaccine.2011.07.044

Table 2.

Demographics and Characteristics of 76 Cases Reviewed, CISA Clinical Case Review, 2004-2009

Age
    Range (IQR) 2 days – 85 years (1.3 - 26)
    < 18 yr, n (%) 49 (64.5%)
    > = 18 yr, n (%) 27 (35.5%)
Female 40 (52.6%)
Current or chronic medical conditiona
    Yes 44 (57.9%)
    No 27 (35.5%)
Underlying known medical conditionsb
    Atopy (asthma +/− eczema +/− allergic rhinitis +/− food allergy) 13 (17.1%)
    Immune abnormality (SCIDc, cancer, Kawasaki disease, congenital neutropenia, pregnancy) 6 (7.9%)
    Autoimmune disorders (psoriasis, thyroid disorder, Sjogren's syndrome) 4 (5.3%)
    Previous similar reaction or event 3 (4.0%)
    Multiple medical problems 9 (11.8%)
    Known medical history that could be causal (i.e., specific medicine associated with event, acute worsening of previous condition) 13 (17.1%)
a

Data on past medical history available from 71 (93.4%) cases

b

categories are not mutually exclusive

c

Severe Combined Immunodefiency